What's New at CBER 3/4/2024 U.S. Food and Drug Administration sent this bulletin at 03/04/2024 04:42 PM EST What's New at CBER You are subscribed to What's New at CBER for the U.S. Food & Drug Administration (FDA) What's New Today The following links have been updated recently: Posted: 3/4/2024 March 1, 2024 Approval Letter - AFLURIA Summary of Safety and Probable Benefit (SSPB) - QUELIMMUNE March 1, 2024 Approval Letter - BIVIGAM March1, 2024 Approval Letter - ASCENIV Complete List of Licensed Products and EstablishmentsUpdate Complete List of Substantially Equivalent 510(k) Device ApplicationsUpdate Complete List of Currently Approved Premarket Approvals (PMAs)Update Complete List of Currently Approved NDA and ANDA Application SubmissionsUpdate Workshops, Meetings & Conferences March Vaccines and Related Biological Products Advisory Committee MeetingMarch 5, 2024 Considerations for the Development of CAR T Cell ProductsMarch 7, 2024 May Vaccines and Related Biological Products Advisory Committee MeetingMay 16, 2024
